Blood Reviews
Volume 26, Issue 1 , Pages 1-14 , January 2012

The role of dietary vitamin K in the management of oral vitamin K antagonists

  • Michael V. Holmes

      Affiliations

    • Department of Clinical Pharmacology, Guy's & St Thomas' NHS Foundation Trust, London, UK
    • Department of Epidemiology & Public Health, University College London, 1-19 Torrington Place, London WC1E 6BT, UK
    • ,
  • Beverley J. Hunt

      Affiliations

    • Department of Thrombosis & Haemostasis, Kings College, London, UK
    • Departments of Haematology, Lupus & Pathology, Guy's & St Thomas' NHS Foundation Trust, London SE1 7EH, UK
    • ,
  • Martin J. Shearer

      Affiliations

    • Centre for Haemostasis and Thrombosis, Guys & St Thomas' NHS Foundation Trust, Westminster Bridge Road, London SE1 7EH, UK
    • Haemostasis Research Unit, Guy's & St Thomas' NHS Foundation Trust, and King's College, London, UK
    • Corresponding Author InformationCorresponding author at: Centre for Haemostasis & Thrombosis, First Floor North Wing, St Thomas' Hospital, Westminster Bridge Road, London SE1 7EH, UK. Tel.: +44 20 7188 2801; fax: +44 20 7401 3125.

References 

  1. Link KP. The discovery of dicumarol and its sequels. Circulation. 1959;19:97–107
  2. Suttie JW. Vitamin K in health and disease. First ed.. Boca Raton: CRC Press (Taylor & Francis Group; 2009;
  3. Wadelius M, Chen LY, Lindh JD, Eriksson N, Ghori MJ, Bumpstead S, et al. The largest prospective warfarin-treated cohort supports genetic forecasting. Blood. 2009;113:784–792
  4. Rettie AE, Wienkers LC, Gonzalez FJ, Trager WF, Korzekwa KR. Impaired (S)-warfarin metabolism catalysed by the R144C allelic variant of CYP2C9. Pharmacogenetics. 1994;4:39–42
  5. Kamali F, Wynne H. Pharmacogenetics of warfarin. Annu Rev Med. 2010;61:63–75
  6. Caldwell MD, Awad T, Johnson JA, Gage BF, Falkowski M, Gardina P, et al. CYP4F2 genetic variant alters required warfarin dose. Blood. 2008;111:4106–4112
  7. McDonald MG, Rieder MJ, Nakano M, Hsia CK, Rettie AE. CYP4F2 is a vitamin K1 oxidase: an explanation for altered warfarin dose in carriers of the V433M variant. Mol Pharmacol. 2009;75:1337–1346
  8. Shearer MJ, McBurney A, Barkhan P. Studies on the absorption and metabolism of phylloquinone (vitamin K1) in man. Vitam Horm. 1974;32:513–542
  9. Harrington DJ, Soper R, Edwards C, Savidge GF, Hodges SJ, Shearer MJ. Determination of the urinary aglycone metabolites of vitamin K by HPLC with redox-mode electrochemical detection. J Lipid Res. 2005;46:1053–1060
  10. Nakagawa K, Hirota Y, Sawada N, Yuge N, Watanabe M, Uchino Y, et al. Identification of UBIAD1 as a novel human menaquinone-4 biosynthetic enzyme. Nature. 2010;468:117–121
  11. World Health Organization International Agency for Research on Cancer . IARC monographs on the evaluation of carcinogenic risks to humans. In: Some antiviral and antineoplastic drugs, and other pharmaceutical agents. 76:Lyon: IARC Press; 2000;p. 417–486
  12. Hanson HH, Barker NW, Mann FD. Clinical experiences with 4-hydroxycoumarin anticoagulant no. 63 and the antagonistic effect of menadione and vitamin K. Circulation. 1951;4:844–863
  13. Shearer MJ, Newman P. Metabolism and cell biology of vitamin K. Thromb Haemost. 2008;100:530–547
  14. Furie B, Bouchard BA, Furie BC. Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid. Blood. 1999;93:1798–1808
  15. Wu S, Liu S, Davis CH, Stafford DW, Kulman JD, Pedersen LG. A hetero-dimer model for concerted action of vitamin K carboxylase and vitamin K reductase in vitamin K cycle. J Theor Biol. 2011;279:143–149
  16. Park BK. Warfarin: metabolism and mode of action. Biochem Pharmacol. 1988;37:19–27
  17. Price R, Fenton S, Shearer MJ, Bolton-Smith C. Daily and seasonal variation in phylloquinone (vitamin K1) intake in Scotland. Proc Nutr Soc. 1996;55:244A
  18. Harrington DJ, Booth SL, Card DJ, Shearer MJ. Excretion of the urinary 5C- and 7C-aglycone metabolites of vitamin K by young adults responds to changes in dietary phylloquinone and dihydrophylloquinone intakes. J Nutr. 2007;137:1763–1768
  19. Olson RE, Chao J, Graham D, Bates MW, Lewis JH. Total body phylloquinone and its turnover in human subjects at two levels of vitamin K intake. Br J Nutr. 2002;87:543–553
  20. Shea MK, Booth SL, Gundberg CM, Peterson JW, Waddell C, Dawson-Hughes B, et al. Adulthood obesity is positively associated with adipose tissue concentrations of vitamin K and inversely associated with circulating indicators of vitamin K status in men and women. J Nutr. 2010;140:1029–1034
  21. Shearer MJ, Harrington DJ, Bolton-Smith C, Clark KGA, Savidge GF. A very low, fixed dose of warfarin has a minimal effect on the gamma-carboxylation of the vitamin K dependent coagulation factors but perturbs vitamin K metabolism. J Thromb Haemost. 1997;(Supplement:708):(Abstract)
  22. McCann JC, Ames BN. Vitamin K, an example of triage theory: is micronutrient inadequacy linked to diseases of aging?. Am J Clin Nutr. 2009;90:889–907
  23. Shearer MJ, Bach A, Kohlmeier M. Chemistry, nutritional sources, tissue distribution and metabolism of vitamin K with special reference to bone health. J Nutr. 1996;126:1181S–1186S
  24. Schurgers LJ, Vermeer C. Determination of phylloquinone and menaquinones in food. Effect of food matrix on circulating vitamin K concentrations. Haemostasis. 2000;30:298–307
  25. Conly JM, Stein K. Quantitative and qualitative measurements of K vitamins in human intestinal contents. Am J Gastroenterol. 1992;87:311–316
  26. Suttie JW. The importance of menaquinones in human nutrition. Annu Rev Nutr. 1995;15:399–417
  27. Shearer MJ, Vitamin K. Metabolism and nutriture. Blood Rev. 1992;6:92–104
  28. Booth SL, Al Rajabi A. Determinants of vitamin K status in humans. Vitam Horm. 2008;78:1–22
  29. Parrish DB. Determination of vitamin K in foods: a review. Crit Rev Food Sci Nutr. 1980;13:337–352
  30. Shearer MJ, Bolton-Smith C. The UK food data-base for vitamin K and why we need it. Food Chem. 2000;68:213–218
  31. Booth SL, Sadowski JA, Weihrauch JL, Ferland G. Vitamin K1 (Phylloquinone) content of foods: a provisional table. J Food Compos Anal. 1993;6:109–120
  32. Booth SL, Sadowski JA, Pennington JAT. Phylloquinone (Vitamin K1) content of foods in the U.S. food and drug administration's total diet study. J Agric Food Chem. 1995;43:1574–1579
  33. Bolton-Smith C, Price RJ, Fenton ST, Harrington DJ, Shearer MJ. Compilation of a provisional UK database for the phylloquinone (vitamin K1) content of foods. Br J Nutr. 2000;83:389–399
  34. McCance , Widdowson's . The Composition of foods. 6th Revised ed.. United Kingdom: Royal Society of Chemistry; 2002;
  35. Agricultural Research Service . USDA National Nutrient Database for standard reference. In: Release 17 vitamin K (phylloquinone) (μg) content of selected foods per common measure, sorted alphabetically. US Department of Agriculture; 2004;Available at http://www.nal.usda.gov/fnic/foodcomp/Data/SR17/wtrank/sr17a430.pdf
  36. Ferland G, Sadowski JA. Vitamin K1 (phylloquinone) content of green vegetables: effects of plant maturation and geographical growth location. J Agric Food Chem. 1992;40:1874–1877
  37. Ferland G, Sadowski JA. Vitamin K1 (phylloquinone) content of edible oils: effects of heating and light exposure. J Agric Food Chem. 1992;40:1869–1873
  38. Matschiner JT, Amelotti JM. Characterization of vitamin K from bovine liver. J Lipid Res. 1968;9:176–179
  39. Duello TJ, Matschiner JT. Characterization of vitamin K from pig liver and dog liver. Arch Biochem Biophys. 1971;144:330–338
  40. Duello TJ, Matschiner JT. Characterization of vitamin K from human liver. J Nutr. 1972;102:331–335
  41. Nelson M. Methods and validity of dietary assessment. In:  Garrow JS,  James WPT,  Ralph A editor. Human nutrition and dietetics. 10th ed.. Edinburgh: Churchill Livingstone; 1999;
  42. Bingham SA, Gill C, Welch A, Day K, Cassidy A, Khaw KT, et al. Comparison of dietary assessment methods in nutritional epidemiology: weighed records v. 24h recalls, food-frequency questionnaires and estimated-diet records. Br J Nutr. 1994;72:619–643
  43. Schurgers LJ, Geleijnse JM, Grobbee DE, Pols HAP, Hofman A, Witteman JCM, et al. Nutritional intake of vitamins K1 (Phylloquinone) and K2 (Menaquinone) in The Netherlands. J Nutr Environ Med. 1999;9:115–122
  44. Geleijnse JM, Vermeer C, Grobbee DE, Schurgers LJ, Knapen MH, van der Meer IM, et al. Dietary intake of menaquinone is associated with a reduced risk of coronary heart disease: the Rotterdam Study. J Nutr. 2004;134:3100–3105
  45. Nimptsch K, Rohrmann S, Linseisen J. Dietary intake of vitamin K and risk of prostate cancer in the Heidelberg cohort of the European Prospective Investigation into Cancer and Nutrition (EPIC-Heidelberg). Am J Clin Nutr. 2008;87:985–992
  46. Booth SL, Sokoll LJ, O'Brien ME, Tucker K, Dawson-Hughes B, Sadowski JA. Assessment of dietary phylloquinone intake and vitamin K status in postmenopausal women. Eur J Clin Nutr. 1995;49:832–841
  47. Booth SL, Suttie JW. Dietary intake and adequacy of vitamin K. J Nutr. 1998;128:785–788
  48. Thane CW, Paul AA, Bates CJ, Bolton-Smith C, Prentice A, Shearer MJ. Intake and sources of phylloquinone (vitamin K1): variation with socio-demographic and lifestyle factors in a national sample of British elderly people. Br J Nutr. 2002;87:605–613
  49. Thane CW, Bolton-Smith C, Coward WA. Comparative dietary intake and sources of phylloquinone (vitamin K1) among British adults in 1986–7 and 2000-1. Br J Nutr. 2006;96:1105–1115
  50. Cushman M, Booth SL, Possidente CJ, Davidson KW, Sadowski JA, Bovill EG. The association of vitamin K status with warfarin sensitivity at the onset of treatment. Br J Haematol. 2001;112:572–577
  51. Khan T, Wynne H, Wood P, Torrance A, Hankey C, Avery P, et al. Dietary vitamin K influences intra-individual variability in anticoagulant response to warfarin. Br J Haematol. 2004;124:348–354
  52. Sobczyńska-Malefora A, Harrington DJ, Lomer MC, Pettitt C, Hamilton S, Rangarajan S, et al. Erythrocyte folate and 5-methyltetrahydrofolate levels decline during 6months of oral anticoagulation with warfarin. Blood Coagul Fibrinolysis. 2009;20:297–302
  53. Food and Nutrition Board, Institute of Medicine . Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, manganese, molybdenum, nickel, silicon, vanadium and zinc. Washington, DC: National Academy Press; 2001;
  54. Johnson MA. Influence of vitamin K on anticoagulant therapy depends on vitamin K status and the source and chemical forms of vitamin K. Nutr Rev. 2005;63:91–97
  55. Spratto GR, Woods AL. PDR nurse's drug handbook. Revised ed: Thomson PDR; 2002;
  56. Wells PS, Holbrook AM, Crowther NR, Hirsh J. Interactions of warfarin with drugs and food. Ann Intern Med. 1994;121:676–683
  57. Harris JE. Interaction of dietary factors with oral anticoagulants: review and applications. J Am Diet Assoc. 1995;95:580–584
  58. Lubetsky A, Dekel-Stern E, Chetrit A, Lubin F, Halkin H. Vitamin K intake and sensitivity to warfarin in patients consuming regular diets. Thromb Haemost. 1999;81:396–399
  59. Food and Nutrition Board . Recommended dietary allowances (dietary reference intakes). 10th Revised ed.. Washington, DC: National Academies Press; 1989;
  60. Suttie JW. Vitamin K and human nutrition. J Am Diet Assoc. 1992;92:585–590
  61. Lee W, Chung HJ, Kim S, Jang S, Park CJ, Chi HS, et al. PIVKA-II is a candidate marker for monitoring the effects of the oral anticoagulant warfarin. Clin Biochem. 2010;43:1177–1179
  62. Schurgers LJ, Shearer MJ, Hamulyák K, Stöcklin E, Vermeer C. Effect of vitamin K intake on the stability of oral anticoagulant treatment: dose-response relationships in healthy subjects. Blood. 2004;104:2682–2689
  63. Franco V, Polanczyk CA, Clausell N, Rohde LE. Role of dietary vitamin K intake in chronic oral anticoagulation: prospective evidence from observational and randomized protocols. Am J Med. 2004;116:651–656
  64. Sconce E, Khan T, Mason J, Noble F, Wynne H, Kamali F. Patients with unstable control have a poorer dietary intake of vitamin K compared to patients with stable control of anticoagulation. Thromb Haemost. 2005;93:872–875
  65. Rombouts EK, Rosendaal FR, van der Meer FJ. Influence of dietary vitamin K intake on subtherapeutic oral anticoagulant therapy. Br J Haematol. 2010;149:598–605
  66. Presse N, Kergoat MJ, Ferland G. High usual dietary vitamin K intake is associated with low relative variability in vitamin K intake: implications for anticoagulant therapy. Br J Haematol. 2011;153:129–130
  67. Kim KH, Choi WS, Lee JH, Lee H, Yang DH, Chae SC. Relationship between dietary vitamin K intake and the stability of anticoagulation effect in patients taking long-term warfarin. Thromb Haemost. 2010;104:755–759
  68. Usui Y, Tanimura H, Nishimura N, Kobayashi N, Okanoue T, Ozawa K. Vitamin K concentrations in the plasma and liver of surgical patients. Am J Clin Nutr. 1990;51:846–852
  69. Caldwell PT, Ren P, Bell RG. Warfarin and metabolism of vitamin K1. Biochem Pharmacol. 1974;23:3353–3362
  70. Shearer MJ, McBurney A, Barkhan P. Effect of warfarin anticoagulation on vitamin-K 1 metabolism in man. Br J Haematol. 1973;24:471–479
  71. Shearer MJ, McBurney A, Breckenridge AM, Barkhan P. Effect of warfarin on the metabolism of phylloquinone (vitamin K1):dose-response relationships in man. Clin Sci Mol Med. 1977;52:621–630
  72. Choonara IA, Scott AK, Haynes BP, Cholerton S, Breckenridge AM, Park BK. Vitamin K1 metabolism in relation to pharmacodynamic response in anticoagulated patients. Br J Clin Pharmacol. 1985;20:643–648
  73. Park BK, Choonara IA, Haynes BP, Breckenridge AM, Malia RG, Preston FE. Abnormal vitamin K metabolism in the presence of normal clotting factor activity in factory workers exposed to 4-hydroxycoumarins. Br J Clin Pharmacol. 1986;21:289–293
  74. Kamali F, Edwards C, Butler TJ, Wynne HA. The influence of (R)- and (S)-warfarin, vitamin K and vitamin K epoxide upon warfarin anticoagulation. Thromb Haemost. 2000;84:39–42
  75. Kurnik D, Lubetsky A, Loebstein R, Almog S, Halkin H. Multivitamin supplements may affect warfarin anticoagulation in susceptible patients. Ann Pharmacother. 2003;37:1603–1606
  76. Kurnik D, Loebstein R, Rabinovitz H, Austerweil N, Halkin H, Almog S. Over-the-counter vitamin K1-containing multivitamin supplements disrupt warfarin anticoagulation in vitamin K1-depleted patients. A prospective, controlled trial. Thromb Haemost. 2004;92:1018–1024
  77. Owren PA. Thrombotest. A new method for controlling anticoagulant therapy. Lancet. 1959;2:754–758
  78. Owren PA. The interrelationship between Normotest and Thrombotest. Farmakoterapi. 1969;25:1–13
  79. Multicentre evaluation of Normotest performance characteristics. Interlab variation, comparison of manual and instrumental techniques, reproducibility, normal range. Italian CISMEL study group. Scand J Haematol. 1984;32:501–506
  80. Arnesen H, Smith P. The predictability of bleeding by prothrombin times sensitive or insensitive to PIVKA during intensive oral anticoagulation. Thromb Res. 1991;61:311–314
  81. Karlson B, Leijd B, Hellstrom K. On the influence of vitamin K-rich vegetables and wine on the effectiveness of warfarin treatment. Acta Med Scand. 1986;220:347–350
  82. Pedersen FM, Hamberg O, Hess K, Ovesen L. The effect of dietary vitamin K on warfarin-induced anticoagulation. J Intern Med. 1991;229:517–520
  83. Gijsbers BL, Jie KS, Vermeer C. Effect of food composition on vitamin K absorption in human volunteers. Br J Nutr. 1996;76:223–229
  84. Garber AK, Binkley NC, Krueger DC, Suttie JW. Comparison of phylloquinone bioavailability from food sources or a supplement in human subjects. J Nutr. 1999;129:1201–1203
  85. Schurgers LJ, Teunissen KJ, Hamulyák K, Knapen MH, Vik H, Vermeer C. Vitamin K-containing dietary supplements: comparison of synthetic vitamin K1 and natto-derived menaquinone-7. Blood. 2007;109:3279–3283
  86. Vermeer C, Shearer MJ, Zittermann A, Bolton-Smith C, Szulc P, Hodges S, et al. Beyond deficiency: potential benefits of increased intakes of vitamin K for bone and vascular health. Eur J Nutr. 2004;43:325–335
  87. Kudo T. Warfarin antagonism of natto and increase in serum vitamin K by intake of natto. Artery. 1990;17:189–201
  88. Sconce E, Avery P, Wynne H, Kamali F. Vitamin K supplementation can improve stability of anticoagulation for patients with unexplained variability in response to warfarin. Blood. 2007;109:2419–2423
  89. Rombouts EK, Rosendaal FR, Van Der Meer FJ. Daily vitamin K supplementation improves anticoagulant stability. J Thromb Haemost. 2007;5:2043–2048
  90. Bonjour JP, Gueguen L, Palacios C, Shearer MJ, Weaver CM. Minerals and vitamins in bone health: the potential value of dietary enhancement. Br J Nutr. 2009;101:1581–1596
  91. Schurgers LJ, Cranenburg EC, Vermeer C. Matrix Gla-protein: the calcification inhibitor in need of vitamin K. Thromb Haemost. 2008;100:593–603
  92. Cockayne S, Adamson J, Lanham-New S, Shearer MJ, Gilbody S, Torgerson DJ. Vitamin K and the prevention of fractures: systematic review and meta-analysis of randomized controlled trials. Arch Intern Med. 2006;166:1256–1261
  93. Conway SP. Vitamin K in cystic fibrosis. J R Soc Med. 2004;97(Suppl 44):48–51
  94. EFSA panel on dietetic products Nutrition and Allergies (NDA). In: Scientific opinion on the substantiation of health claims related to vitamin K and maintenance of bone (ID 123, 127, 128 and 2879), blood coagulation (ID 124 and 126) and function of the heart and blood vessels (ID 124, 125 and 2880) pursuant to Article 13(1) of Regulation (EC) No 1924/2006 on request from the European Commission. 7:EFSA; 2009;p. 1228;Available online www.efsa.europa.eu
  95. de Assis MC, Rabelo ER, Avila CW, Polanczyk CA, Rohde LE. Improved oral anticoagulation after a dietary vitamin k-guided strategy: a randomized controlled trial. Circulation. 2009;120:1115–11223 p following 22
  96. Hylek EM, Heiman H, Skates SJ, Sheehan MA, Singer DE. Acetaminophen and other risk factors for excessive warfarin anticoagulation. Jama. 1998;279:657–662
  97. Jones KS, Bluck LJ, Wang LY, Stephen AM, Prynne CJ, Coward WA. The effect of different meals on the absorption of stable isotope-labelled phylloquinone. Br J Nutr. 2009;102:1195–1202
  98. Custodio das Dores SM, Booth SL, Martini LA, de Carvalho Gouvea VH, Padovani CR, de Abreu Maffei FH, et al. Relationship between diet and anticoagulant response to warfarin: a factor analysis. Eur J Nutr. 2007;46:147–154

PII: S0268-960X(11)00054-3

doi: 10.1016/j.blre.2011.07.002

Blood Reviews
Volume 26, Issue 1 , Pages 1-14 , January 2012

Article Tools

* Image Usage & Resolution